Avalo Therapeutics (AVTX) Stock Insights

AVTX price $6.75 +0.00 +0.03%

Ticker
AVTX
Price
$6.75
Change
+0.00 +0.03%
Market cap ?
$362.09M
P/E ?
-1.57
Dividend yield ?
0.00%
Beta ?
0.79
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
46
Value
59
Quality
30
Growth
50

Stocklytics score rationale: value 59, quality 30, growth 50.

Financials

2016201720182019202020212022202320242025
1153000278131371832680167503516699000539800018051000192400044100059000

Avalo Therapeutics, Inc. is a precision medicine company in the clinical development phase, dedicated to identifying, advancing, and marketing specialized treatments for patients experiencing critical unmet medical needs across the fields of immunology, immuno-oncology, and rare genetic disorders. Among its key pipeline assets is AVTX-002, a fully human monoclonal antibody designed to inhibit LIGHT. This drug is…

Fair value

AVTX fair value $71,254.97. Price $6.75. Price is 100% below fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Model uncertainty high for this stock

Compare AVTX

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-05—-0.59——
2026-08-06-0.83-0.58——
2026-05-13-0.98-1.00——
2026-03-23-0.74-1.5479.50K—
2025-11-06-2.19-1.67——
2025-08-07-1.92-1.43——
2025-05-12-1.25-1.07——
2025-03-27-2.30-1.29200.00K300.00K
2024-11-07-2.83-1.19249.00K—
2024-08-12-14.07-6.70——
2024-07-11-141.14———
2024-05-13-5.98-1.18571.00K—
2023-11-09-26.19-261.90236.00K300.00K
2023-08-03-140.48-214.29643.00K500.00K
2023-05-04-202.38-230.95475.00K1.00M
2023-03-29-247.62-123.81896.00K3.61M
2022-11-0780.95-245.2414.95M1.26M
2022-08-04-328.57-428.571.03M1.19M
2022-05-05-571.66-400.161.17M645.50K
2022-03-02-1.92-1.90219.00K1.02M
2021-11-09-485.91-543.071.35M810.00K
2021-08-02-2.16-2.043.35M3.35M
2021-05-13-3.84-2.32473.00K369.69K
2021-03-08-2.16-1.801.50M1.00M
2020-11-09-2.04-1.141.11M1.03M
2020-08-06-2.28-1.261.34M1.12M
2020-05-07-4.08-1.222.75M809.96K
2020-03-110.360.84-8.72M15.75M
2019-11-14-0.84-1.605.61M10.42M
2019-08-08-1.32-1.744.45M1.77M
2019-05-09-1.56-1.965.41M3.17M
2019-03-18-2.16-0.604.98M1.95M
2018-11-13-2,045.01—4.07M—
2018-08-09-536.57—4.79M—
2018-05-11-357.08—4.48M—
2018-04-02-1.19—2.23M—
2017-11-066.30—25.04M—
2017-08-14-1.63—157.80K—
2017-05-09-2.28-4.44384.21K748.19K
2017-03-14-2.16-8.04182.00K673.73K

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-09-30Jain RitaBuy1.32K$15.3320.27K
2026-09-30Lind Kevin RobertBuy1.35K$15.3320.73K
2026-09-30Philip Ron MBuy1.11K$15.3317.00K
2026-09-16Sullivan Christopher RyanSell12.39K$9.88122.45K
2026-09-16Sullivan Christopher RyanBuy12.39K$9.88122.45K
2026-09-16Sullivan Christopher RyanSell12.39K$16.33202.44K
2026-09-10Sullivan Christopher RyanSell10.19K$8.0481.89K
2026-09-10Sullivan Christopher RyanBuy10.19K$8.0481.89K
2026-09-10Sullivan Christopher RyanSell10.19K$17.62179.46K
2026-08-28Doyle MittieSell679$8.045.46K
2026-08-28Doyle MittieBuy679$8.045.46K
2026-08-28Doyle MittieSell679$20.0013.58K
2026-08-18Sullivan Christopher RyanSell31.03K$9.88306.59K
2026-08-18Sullivan Christopher RyanBuy31.03K$9.88306.59K
2026-08-18Sullivan Christopher RyanSell31.03K$20.05622.32K
2026-08-17Sullivan Christopher RyanSell37.95K$9.88374.90K
2026-08-17Sullivan Christopher RyanSell2.88K$9.8828.41K
2026-08-17Sullivan Christopher RyanBuy2.88K$9.8828.41K
2026-08-17Sullivan Christopher RyanBuy37.95K$9.88374.90K
2026-08-17Sullivan Christopher RyanSell37.95K$19.85753.33K
2026-08-17Sullivan Christopher RyanSell3.75K$19.9474.76K
2026-08-17Doyle MittieSell1.00K$12.6512.65K
2026-08-17Doyle MittieBuy1.00K$12.6512.65K
2026-08-17Doyle MittieSell1.00K$20.0020.00K
2026-08-11Riley JenniferSell2.65K$19.5952.01K
2026-08-10Doyle MittieSell679$8.045.46K
2026-08-10Doyle MittieBuy679$8.045.46K
2026-08-10Doyle MittieSell679$20.0013.58K
2026-07-27Doyle MittieSell1.00K$12.6512.65K
2026-07-27Doyle MittieBuy1.00K$12.6512.65K
2026-07-27Doyle MittieSell1.00K$20.0020.00K
2026-06-30Doyle MittieSell2.88K$12.6536.37K
2026-06-30Doyle MittieSell1.78K$8.0414.30K
2026-06-30Doyle MittieBuy1.78K$8.0414.30K
2026-06-30Doyle MittieBuy2.88K$12.6536.37K
2026-06-30Doyle MittieSell4.65K$20.0093.08K
2026-06-30Philip Ron MBuy69$18.481.28K
2026-06-30Lind Kevin RobertBuy1.10K$18.4820.42K
2026-06-30Jain RitaBuy1.08K$18.4819.96K
2026-06-23Doyle MittieSell1.45K$8.0411.66K
2026-06-23Doyle MittieBuy1.45K$8.0411.66K
2026-06-23Doyle MittieSell1.45K$18.0026.10K
2026-06-23Philip Ron MBuy40.20K$17.83716.77K
2026-06-23Philip Ron MOther0——
2026-06-10Riley JenniferSell588$13.107.70K
2026-06-10VARKI PAULSell1.08K$13.1014.16K
2026-06-10Sullivan Christopher RyanSell138$13.101.81K
2026-06-10Doyle MittieSell1.08K$13.1014.20K
2026-06-02Lind Kevin RobertBuy20.10K$13.96280.60K
2026-06-02Truex SamanthaBuy20.10K$13.96280.60K
2026-06-02KAPLAN GILLABuy20.10K$13.96280.60K
2026-06-02KANTOFF AARONBuy20.10K$13.96280.60K
2026-06-02Heffernan Michael ThomasBuy29.50K$13.96411.82K
2026-06-02Jain RitaBuy20.10K$13.96280.60K
2026-05-28Doyle MittieSell679$8.045.46K
2026-05-28Doyle MittieBuy679$8.045.46K
2026-05-28Doyle MittieSell679$16.0010.86K
2026-05-21Riley JenniferBuy34.20K——
2026-05-21Sullivan Christopher RyanBuy39.90K——
2026-05-21VARKI PAULBuy24.30K——
2026-05-21Doyle MittieBuy43.50K——
2026-05-21NEIL GARRY ARTHURBuy100.20K——
2026-05-15Doyle MittieSell3.00K$12.6537.95K
2026-05-15Doyle MittieBuy3.00K$12.6537.95K
2026-05-15Doyle MittieSell3.00K$18.7656.28K
2026-05-07Sullivan Christopher RyanSell18.61K$9.88183.83K
2026-05-07Sullivan Christopher RyanBuy18.61K$9.88183.83K
2026-05-07Sullivan Christopher RyanSell18.61K$24.12448.82K
2026-05-06VARKI PAULSell62.50K$13.43839.38K
2026-05-06VARKI PAULSell12.56K$8.04101.01K
2026-05-06VARKI PAULBuy12.56K$8.04101.01K
2026-05-06VARKI PAULBuy62.50K$13.43839.38K
2026-05-06VARKI PAULSell37.38K$18.91706.84K
2026-05-06VARKI PAULSell5.20K$19.78102.78K
2026-05-06VARKI PAULSell22.84K$21.22484.54K
2026-05-06VARKI PAULSell9.25K$22.70210.03K
2026-05-06VARKI PAULSell400$23.719.48K
2026-05-06Sullivan Christopher RyanSell47.00K$8.04377.88K
2026-05-06Sullivan Christopher RyanBuy47.00K$8.04377.88K
2026-05-06Sullivan Christopher RyanSell13.83K$18.55256.66K
2026-05-06Sullivan Christopher RyanSell12.35K$19.28238.09K
2026-05-06Sullivan Christopher RyanSell2.70K$20.7656.05K
2026-05-06Sullivan Christopher RyanSell9.22K$21.37197.01K
2026-05-06Sullivan Christopher RyanSell8.90K$22.57200.91K
2026-05-06Doyle MittieSell77.91K$12.65985.50K
2026-05-06Doyle MittieSell28.65K$8.04230.35K
2026-05-06Doyle MittieBuy28.65K$8.04230.35K
2026-05-06Doyle MittieSell27.54K$18.03496.41K
2026-05-06Doyle MittieBuy77.91K$12.65985.50K
2026-05-06Doyle MittieSell5.00K$19.6598.25K
2026-05-06Doyle MittieSell44.94K$21.20952.67K
2026-05-06Doyle MittieSell19.02K$22.41426.05K
2026-05-06Doyle MittieSell10.06K$22.88230.13K
2026-05-06Chan MitchellSell3.17K$22.8872.46K
2026-05-05Doyle MittieSell1.00K$12.6512.65K
2026-05-05Doyle MittieSell679$8.045.46K
2026-05-05Doyle MittieBuy679$8.045.46K
2026-05-05Doyle MittieBuy1.00K$12.6512.65K
2026-05-05Doyle MittieSell1.68K$16.0026.86K
2026-04-30Sullivan Christopher RyanSell8.46K$13.23111.85K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 136, holders +27 vs prior quarter. Ownership 162.58%.

HolderSharesChangeChange %Value
FMR LLC5.10M2.22M+77.12%94.25M
BLACKROCK, INC.4.37M4.04M+1234.70%80.68M
DEEP TRACK CAPITAL, LP3.61M3.61MNew66.71M
CALIGAN PARTNERS LP3.16M1.53M+93.51%58.47M
TCG CROSSOVER MANAGEMENT, LLC3.02M2.28M+308.61%55.76M
AFFINITY ASSET ADVISORS, LLC2.90M1.56M+116.28%53.59M
STATE STREET CORP2.89M2.82M+3932.28%53.39M
FARALLON CAPITAL MANAGEMENT, L.L.C.2.50M1.58M+172.71%46.16M
POINT72 ASSET MANAGEMENT, L.P.2.39M1.47M+160.55%44.11M
AVORO CAPITAL ADVISORS LLC2.33M923.33K+65.48%43.12M
VANGUARD CAPITAL MANAGEMENT LLC2.26M1.54M+214.61%41.84M
BVF INC/IL2.08M442.70K+27.11%38.36M
BANK OF AMERICA CORP /DE/1.91M1.27M+197.64%35.37M
NANTAHALA CAPITAL MANAGEMENT, LLC1.86M627.25K+50.79%34.41M
ADAGE CAPITAL PARTNERS GP, L.L.C.1.73M875.00K+102.46%31.95M
SOLEUS CAPITAL MANAGEMENT, L.P.1.65M1.21M+274.45%30.58M
BRAIDWELL LP1.63M1.63MNew30.11M
PRICE T ROWE ASSOCIATES INC /MD/1.31M1.31MNew24.24M
ALLIANCEBERNSTEIN L.P.1.26M1.26MNew23.30M
UBS GROUP AG1.21M67.08K+5.87%22.34M
LOGOS GLOBAL MANAGEMENT LP1.15M850.00K+283.33%21.25M
GEODE CAPITAL MANAGEMENT, LLC1.11M935.23K+550.49%20.43M
COMMODORE CAPITAL LP1.02M535.32K+110.83%18.82M
RA CAPITAL MANAGEMENT, L.P.1.00M337.03K+50.84%18.48M
GOLDMAN SACHS GROUP INC946.32K886.21K+1474.42%17.49M

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Avalo Therapeutics (AVTX) Stock Insights

AVTX$6.75+0.00 +0.03%

$362.09M

Market Cap

-1.57

P/E

—

Forward P/E

46

Score

Price History